The Lineberger Cancer Research Center of the University of North Carolina, was started in 1975 to promote interdisciplinary cancer- related research. It is now a strong established entity with a comprehensive array of basic and cancer control research programs linked to fast-growing programs in all major aspects of clinical oncology. The Center's specially designed recently constructed building serves as headquarters for programs with 118 core faculty and 69 associate faculty. The research programs are Tumor Immunology, Tumor Virology, Cancer Cell Biology, Chemical Carcinogenesis, Drug Development, Cancer Epidemiology, Clinical Research and Cancer Prevention. At the disposal of the Director is a broadly based budget exceeding $7 million annually comprised of Federal, State, University and private components, coupled with the mandate and authority to organize and to maintain a coordinated plan for the cancer research enterprise at Chapel Hill. In this, our fourth renewal application, we request: 1. Support for the Center's senior leadership who plan, organize and implement the cancer effort at the University of North Carolina. 2. Support for selected Cancer Center staff investigators following NCI guidelines. 3. Provision of partial support for the administrative functions of the Center. 4. Support for continuation of the successful established Cancer Research Center core facilities plus several new core facilities selected to stimulate new activities. 5. Support for recruitment of faculty members in specific areas critical to the further development of our programs. This application is designed to continue the development of the Center, especially in linking the basic research programs to the developing clinical programs, and bring it fully to realization as a force for innovation and coordination of cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-17
Application #
3101553
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1981-08-01
Project End
1994-05-31
Budget Start
1991-06-01
Budget End
1992-05-31
Support Year
17
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Parr, Jonathan B; Lodge, Evans K; Holzmayer, Vera et al. (2018) An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots. Clin Infect Dis 66:254-260
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5

Showing the most recent 10 out of 1525 publications